Cargando…
Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
Autores principales: | Hurle, Rodolfo, Maccagnano, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473177/ https://www.ncbi.nlm.nih.gov/pubmed/33029408 http://dx.doi.org/10.1080/2090598X.2020.1772031 |
Ejemplares similares
-
If you can't take any more of this, please press two
por: Petsko, Gregory A
Publicado: (2002) -
Who can take advantage of medically assisted reproduction in Germany?
por: Köppen, Katja, et al.
Publicado: (2021) -
Taking Advantage of the Morpheein Behavior of Peroxiredoxin
in Bionanotechnology
por: Ardini, Matteo, et al.
Publicado: (2021) -
Taking advantage of saliva
por: Van Epps, Heather L.
Publicado: (2006) -
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
por: Fasulo, Vittorio, et al.
Publicado: (2022)